Siemens expands Gamma agreement:
This article was originally published in Clinica
Malvern, Pennsylvania-based subsidiary of Siemens Medical Solutions has gained exclusive worldwide marketing rights to Gamma Medica's molecular imaging product, X-Spect, following an extension of the original agreement in July which had restricted Siemens' rights to the US. X-Spect is a dual modality system for pre-clinical imaging, combining functional nuclear imaging technique with anatomical imaging provided by computed tomography. Since the two companies signed the deal, rocketing sales of X-Spect have led Gamma Medica, of Northridge, California, to record a 400% increase in revenues during its fiscal 2004.
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.